Larry Bernstein, MD
Allergy & Immunology · Forest Hills, NYNPI 1851380950
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $830 of the $929 with a category attached, or 89.3%. 13 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 30.1% of the total. Reporting peaked in 2022 at $242 and has fallen 83.7% since, to $39 in 2025. That places this record below the midpoint for allergy & immunology clinicians in NY, where the typical reported total is $2,174.
Across 61 payments — averaging $15.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$280
- Genentech USA, Inc.$208
- Janssen Products, LP$99
- Novartis$65
- Sanofi$54
- Shire North American Group Inc$45
- plus $178 from 7 others
Across 10 payments — averaging $3393.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$34K
What the payments were for
- Food & beverage$83089%
- Education$9911%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $280 |
| Genentech USA, Inc. | 26 | $208 |
| Janssen Products, LP | 1 | $99 |
| Novartis | 3 | $65 |
| Sanofi | 1 | $54 |
| Shire North American Group Inc | 1 | $45 |
| GSK | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $37 |
| Johnson & Johnson | 3 | $34 |
| Dompe US, Inc. | 1 | $22 |
| Viiv Healthcare Company | 1 | $17 |
| Pfizer | 1 | $17 |
| Merck | 1 | $12 |
How this compares
$929 in reported general payments places this provider in the 35th percentile of 320 allergy & immunology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 58 | $232,219 |
| JulucaDolutegravir/Rilpivirine | 33 | $111,850 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 26 | $101,853 |
| CuvitruImmun Glob G(Igg)/Gly/Iga Ov50 | 16 | $95,242 |
| TivicayDolutegravir Sodium | 29 | $90,173 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 12 | $57,143 |
| PifeltroDoravirine | 33 | $54,910 |
| Efavirenz-Emtric-Tenofov DisopEfavirenz/Emtricit/Tenofovr Df | 14 | $18,777 |
| EdurantRilpivirine Hcl | 13 | $18,693 |
| Darunavir | 12 | $10,955 |
| Maraviroc | 12 | $8,888 |
| Ritonavir | 12 | $1,544 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 29 | $578 |
| Azelastine Hcl | 13 | $414 |
| Fluticasone Propionate | 22 | $219 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Viiv Healthcare CompanyJuluca, Tivicay | $17 | $202,02262 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Cuvitru | $280 | $95,24216 claims |
| Janssen Products, LPSymtuza | $99 | $57,14312 claims |
| MerckPifeltro | $12 | $54,91033 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 320 allergy & immunology providers in New York.
Other allergy & immunology in Forest Hills
- Ujwala KazaNew York$1.1M
- Syed MustafaRochester$948K
- Robert SporterNew York$946K
- Gregory PuglisiPlainview$813K
- Stanley GoldsteinRockville Centre$643K
- Robert TamayevRego Park$321K
- Richard InselNew York$269K
- Payel GuptaBrooklyn$256K
- Luz FonacierMineola$237K
- Mark Davis-LortonTarrytown$206K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.